In Brief: Ketoprofen Rx-to-OTC switch
Ketoprofen Rx-to-OTC switch: Bayer and Whitehall-Robins Rx-to-OTC switch applications for the nonsteroidal anti-inflammatory drug for relief of pain and reduction of fever reaches "approvable" stage at FDA on July 19, three working days following unanimous FDA advisory committee recommendation for approval of the applications on July 14 ("The Pink Sheet" July 17, p. 9)...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth